Herbs (Global Traditional) · Ayurveda
Chirata (Swertia chirata) (Swertia chirata)
Moderate Evidencebotanical4 PubMed Studies
Hermetica Superfood Encyclopedia
Chirata (Swertia chirata) is an Ayurvedic herb containing xanthone compounds that provide hepatoprotective and antioxidant effects. The herb activates detoxification enzymes like glutathione peroxidase and catalase while demonstrating DPPH scavenging activity.
Swertia chirata (Chirata or Chirayata) is an annual or biennial herb native to the temperate Himalayas, particularly regions like Uttarakhand in India, belonging to the Gentianaceae family. The whole plant is harvested and typically dried, powdered, or extracted using solvents like ethanol or hexane for medicinal use.
Currently, no human clinical trials, RCTs, or meta-analyses exist for Swertia chirata - all evidence is preclinical from in vitro and animal studies. One review (PMID: 36113678) summarized ~123 metabolites with antitumor, antiviral, and antimalarial activities from animal/in vitro data, highlighting the significant gap in human clinical validation.
No clinically studied dosage ranges for humans have been established. Preclinical studies used 70% ethanolic extracts at concentrations like 267.80 μg/mL for in vitro tests, while traditional formulations like sudarshana churna include it as a main ingredient without specified quantities. Consult a healthcare provider before starting any new supplement.
Chirata (Swertia chirata) is a bitter medicinal herb with negligible macronutrient contribution in typical therapeutic doses (1-3g dried herb or extract). Key bioactive compounds include: Xanthones - swerchirin (primary hypoglycemic compound, ~0.1-0.5% dry weight), mangiferin (~0.2-0.8% dry weight), swertianin, and bellidifolin; Iridoid glycosides - swertiamarin (major bitter principle, ~1-3% dry weight), sweroside, and gentiopicroside contributing to hepatoprotective and anti-inflammatory activity; Secoiridoids - amarogentin (one of the most bitter natural compounds, ~0.05-0.1% dry weight); Alkaloids - gentianine and enicoflavine in trace amounts (~0.01-0.05%); Flavonoids - isovitexin, isoorientin, and quercetin derivatives (~0.3-0.6% total flavonoids); Triterpenes - oleanolic acid and ursolic acid in small quantities. Mineral content is modest: iron (~2-4 mg/100g dried herb), calcium (~150-200 mg/100g), potassium (~300-400 mg/100g), magnesium (~80-120 mg/100g). Crude fiber content approximately 15-20% dry weight. Protein content approximately 8-12% dry weight with limited nutritional significance. Bioavailability notes: Xanthones like swerchirin demonstrate moderate oral bioavailability enhanced by piperine co-administration; swertiamarin is hydrolyzed in the gut to active aglycone forms; bitter compounds stimulate bile secretion potentially improving fat-soluble nutrient absorption; aqueous extracts yield higher iridoid glycoside content while ethanolic extracts favor xanthone and flavonoid extraction.
Chirata's xanthone compounds activate hepatic detoxification enzymes including glutathione peroxidase, catalase, and superoxide dismutase. The herb demonstrates antioxidant activity through DPPH radical scavenging with an IC50 value of 267.80 μg/mL. Hypoglycemic effects are attributed to xanthone compounds that may influence glucose metabolism pathways.
Current evidence for Chirata is limited to in vitro and animal studies only. Antioxidant activity has been demonstrated in laboratory studies with specific DPPH scavenging measurements. Hepatoprotective effects have been observed in animal models through measurable increases in detoxification enzyme activity. No human clinical trials have been conducted to validate these preliminary findings or establish effective dosages.
Chirata safety data in humans is extremely limited due to lack of clinical trials. Traditional use suggests general tolerability, but specific side effects and contraindications remain undocumented. Potential interactions with diabetes medications may occur due to hypoglycemic activity observed in animal studies. Pregnant and nursing women should avoid use due to insufficient safety data.
